2022 is witnessing a sharp drop in global biotech investments by venture capital funds. Data compiled by Wisdomsmith shows venture capital funds invested $15.8B in biotech and healthcare sector over Jan-Apr’22, as compared to $27B over the same period in 2021. That’s a drop of 41%. While the drop…
Read More We recorded 79 VC/PE transactions pertaining to the global life sciences sector for September 2021, aggregating to a sum of USD 3.3B, as against 96 transactions and USD5.6B in Sep’20. The USA recorded 49 transactions aggregating to a total investment of USD 2.2B. China reported a totally out of character…
Read More
The other day I was talking to a person who is an early-stage investor. He was looking to invest in a food business. He explained to me his criterion: he said his fund wanted to invest in a sales-multiple food business. This foxed me. I have heard of packaged food…
Read More We recorded 94 VC/PE transactions pertaining to the global life sciences sector for May 2021, aggregating to a sum of USD 6.56B. The USA recorded 60 transactions aggregating to a total investment of USD 3.3B. China reported investment of USD 1.8B from 12 VC/PE transactions. Rest of the world accounted…
Read More We recorded 131 VC/PE transactions pertaining to the global life sciences sector for April 2021, aggregating to a sum of USD 6.5B. The USA recorded 88 transactions with total investment of USD 3.8B. China reported investment of USD 585m from 12 VC/PE transactions. Rest of world accounted for 31 transactions…
Read More We recorded 114 venture capital / private equity (VC/PE) transactions pertaining to the global life sciences sector for January 2021, aggregating to a sum of USD 6.275B. USA recorded 64 transactions for with total investment of USD 4B. China reported investment of USD 1B over 15 VC/PE transactions. India saw…
Read More
Ever since its early years, Reliance Industries Limited (RIL), India’s largest private sector enterprise, has believed in running an active treasury. Beyond supporting business requirements, RIL’s treasury has often taken investment positions, in areas like listed equity. In the ‘80s and ‘90s, it was a fairly commonplace practice amongst listed…
Read More
Earlier this week we wrote how on 2 consecutive months, China’s biotech sector had witnessed more than USD1B of venture capital investment. That chart ignored another source of risk capital – IPOs. China has been producing around 1 biotech IPO a month consistently. These are typically pre-revenue R&D companies, but…
Read More For the second month in a row, China’s biotech companies attracted more than USD1B of venture capital investment. Biotech investments crossed USD1B for the first time in April’20. Hence, May is the second consecutive month where VC/PE investments in biotech have crossed USD1B. In terms of amout invested, China inching…
Read More